Dr. Sebastian Oehler will present Philochem’s recent discovery in the field of prostate cancer under the title “From DNA-Encoded Chemistry to ACP3-Targeted Radioligand Therapeutics against Prostate Cancer” on May 13th (Radiopharmaceutical Therapies track).

Follow the link for more details.